Breaking News

Advinus Earns Takeda Milestone

By Kristin Brooks | January 7, 2014

R&D collaboration completes first successful year

Advinus Therapeutics Ltd., the TATA promoted Pharmaceutical R&D Co., has received a $3 million milestone for the first successful year in its R&D collaboration with Takeda Pharmaceutical Co.
 
In October 2012, the companies entered a multi-year, multi-project drug discovery collaboration. Advinus is responsible for carrying out all research required to identify candidate molecules for clinical development in several therapeutic areas, and Takeda is responsible for development and commercialization.
 
"Achievement of the rather challenging first year milestone can be attributed to the truly collaborative nature of our relationship with Takeda as well as Advinus' ability to solve complex problems with efficiency and speed,” said Kasim Mookhtiar, chief scientific officer of Advinus.

Related Contract Manufacturing:

  • When Quality Meets Confidence

    When Quality Meets Confidence

    Dr. Fadia AlKhalil, Vice President of Global Business Development for Laboratory Services, SGS ||November 9, 2016
    A look at global account management for R&D outsourcing

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus